Browsing HLS Student Papers by Title
Now showing items 37-56 of 498
-
BIOPHARMING: UNIQUE CHALLENGES AND POLICY PROPOSALS
(2004)Biopharming is the genetic engineering of plants to produce novel pharmaceuticals and useful industrial compounds. It has the potential to provide revolutionary benefits, but it also raises a host of daunting challenges. ... -
BIOPROSPECTING AND THE CONVENTION ON BIOLOGICAL DIVERSITY
(2000)This paper attempts to assess the economic value of biodiversity to commercial bioprospectors and source countries, surveys the provisions of the CBD that deal directly with bioprospecting, examines the types of legal ... -
Biotechnology and the Labeling Dilemma
(2001)This paper will examine the arguments and motivations underlying the FDA stand against mandatory labeling of genetically engineered foods and ingredients. Part I of the paper will describe FDA’s current ... -
Bioterrorism and the Food Drug Administration: H.R. 3448, Related Legislation, and the FDA’s Expanding Role in Preventing and Responding to Biological Attack
(2002)This paper examines the potential impact of recent and proposed bioterrorism legislation on the U.S. Food and Drug Administration (FDA). It concludes that at least one such piece of legislation, H.R. 3448, the â&eu ... -
Blame Canada?: State Prescription Drug Importation Programs, the Federal Response, and Why Lawmakers Are Up in Arms
(2006)A growing war on drugs threatens to turn septuagenarians into scofflaws and state governors into full-fledged lawbreakers. As American citizens—especially the powerful elderly constituency†... -
Borrowing Trouble: Should the FDA Regulate Human Cloning?
(2000)Less than a year after scientist Ian Wilmut announced the birth of Dolly, the world's first cloned sheep, entrepreneur and physicist Richard Seed stated on National Public Radio that he intended to establish a for-profit ... -
Botanical Drugs: The Next New New Thing?
(2002)While herbal medicines hold great promises for treating diseases, they also have serious limitation in their current forms. Currently the regulatory scheme for herbal medicines in the United States is inadequate and it ... -
Bovine Spongiform Encephalopathy: The Past Present and Future of Mad Cow Disease in the United States
(1998)In an attempt to provide an introductory, yet thorough, discussion of Bovine Spongiform Encephalopathy and its ramifications in the United States, this paper shall: discuss the history of and explain the disease known as ... -
BREAKTRHOUGH BIOTECHNOLOGIES: CAN THE FDA KEEP UP WITH THE SPEED OF SCIENCE?
(2004)Biotechnology advances have the potential to dramatically change the practice of medicine. Currently research is underway to find cures for diseases that were before untreatable, and many biotechnology products are already ... -
A Brief History of Tea: The Rise and Fall of the Tea Importation Act
(2000)The goal of this paper is to provide a general history of the Tea Importation Act of 1897. It focuses on the Act's legislative scheme, the Act's antecedents and amendments, and its legislative history. Special attention ... -
A Brief History of the International Regulation of Wine Production
(2002)Regulations regarding wine production have a profound effect on the character of the wine produced. Such regulations can be found on the local, national, and international levels, but each level must be considered with the ... -
BST FREE: The Debate Over Whether to Allow Voluntary Labeling of Products as "BST Free" Not Derived from Dairy Cows Given the Milk Production Hormone BST
(1994)The debate over whether to label milk and other dairy products as coming from cows injected with the milk production hormone bovine somatotropin (BST or rBGH--recombinant bovine growth hormone) pits consumers, like Darlene ... -
Bundled Systems and Better Law: Against the Leflar Method of Resolving Conflicts of Law
(2015)Suppose Jones is a New Hampshire fireworks dealer. Smith comes up from Massachusetts, buys a cache, and brings it home. One night Smith sets off a Roman Candle in his backyard, but mishandles it and badly injures himself. ... -
Caffeine, Calories, and Coordination: Jurisdictional Developments in Federal Alcohol Regulation
(2012)Even though alcoholic beverages fall under the definition of “food” in the Federal Food, Drug & Cosmetic Act, the Food and Drug Administration (FDA) does not regulate such beverages’ ingredient and nutrition labeling as ... -
Can the FDA Keep Kosher?: Regulation of Kosher Claims on Product Labels
(1998)Product labels blast their message through the supermarket aisles, vying to attract the attention of consumers. However, the advertising means available to manufacturers are limited by laws that regulate the claims that ... -
THE CAPITAL CRISIS IN BIOTECH AND THE INVISIBLE COSTS OF REGULATION
(1995)This paper argues that while the FDA approval process may be trivial in terms of geologic time, it is an eternity when viewed from the perspective of the biotech industry. A delay of even a few months can mean life or death ... -
THE CAPTIVE AUDIENCE: A REVIEW OF PUBLIC INFORMATION ON THE SAFETY OF THE HEPATITIS B VACCINE, ESPECIALLY AS IT IS BEING MANDATED FOR NEWBORNS AND YOUNG CHILDREN
(2000)Based on an evaluation of publicly available information and written from a consumer's perspective, this paper will present some of the known problems and most contested issues surrounding the safety of the hepB vaccine, ... -
Carbohydrate Nutrient Content Claims: Proposals for FDA Action and Lessons for Regulatory Response to Emerging Consumer Trends
(2006)This paper considers the recent experience of the low-carbohydrate trend in nutrition. During the early years of this decade, thousands of new products claiming to be low in carbohydrates appeared on supermarket shelves ... -
Carbophobia: The Dieting Public's Obsession with Carbohydrates and the U.S. Government's Response
(2003)This paper examines the recent low-carbohydrate diet craze, and analyzes the reaction of the United States government to new scientific evidence potentially indicating that the government’s current food ...